Abstract: A mobile deactivation apparatus for deactivating contaminants within a defined region that includes a source of a vaporous deactivating agent, a gas handling system, a support member, a drive means, a control system, and a power system is disclosed. The gas handling system dispenses the vaporous deactivating agent to the defined region. The support member is movable in the defined region and supports the source of the vaporous deactivating agent and the gas handling system. The support member can be propelled by the drive means. The control system is programmed to control the operation of the gas handling system and the drive means. A power system is provided to supply power to the mobile deactivation apparatus.

Abstract: The disclosed invention relates to prion deactivating compositions and methods for using the same. The prion deactivating composition may comprise at least one prion denaturing agent and at least one prion deactivating enzyme. The invention relates to a method of cleaning and/or sterilizing a material contaminated with infectious proteins.

Abstract: A method of decontaminating a surface or liquid which is contaminated with prions includes treating the surface with a composition which includes one or more phenol. Phenols which are particularly effective include p-chloro-m-xylanol, thymol, triclosan, 4-chloro, 3-methylphenol, pentachlorophenol, hexachlorophene, 2,2-methyl-bis(4-chlorophenol), and p-phenylphenol.

Abstract: An oxidizing liquid (20), such as hydrogen peroxide, is vaporized (18) and the vapor is used to deactivate nerve gas, blistering gas, or other biologically active substances such as pathogens, biotoxins, and prions. A second chemical compound (42) in vapor, mist, or fog form is used in conjunction with the oxidizing vapor. In one embodiment, the second chemical preconditions the biologically active substances to be deactivated more efficiently by the oxidizing vapor. In another embodiment, the second chemical boosts the reactivity of the oxidizing vapor. In another embodiment, the other chemical reacts with the oxidizing vapor to form an intermediate compound that deactivates at least some of the biologically active substances.

Abstract: A mobile deactivation apparatus for deactivating contaminants within a defined region that includes a source of a vaporous deactivating agent, a gas handling system, a support member, a drive means, a control system, and a power system is disclosed. The gas handling system dispenses the vaporous deactivating agent to the defined region. The support member is movable in the defined region and supports the source of the vaporous deactivating agent and the gas handling system. The support member can be propelled by the drive means. The control system is programmed to control the operation of the gas handling system and the drive means. A power system is provided to supply power to the mobile deactivation apparatus.

Abstract: A mobile deactivation apparatus for deactivating contaminants within a defined region that includes a source of a vaporous deactivating agent, a gas handling system, a support member, a drive means, a control system, and a power system is disclosed. The gas handling system dispenses the vaporous deactivating agent to the defined region. The support member is movable in the defined region and supports the source of the vaporous deactivating agent and the gas handling system. The support member can be propelled by the drive means. The control system is programmed to control the operation of the gas handling system and the drive means. A power system is provided to supply power to the mobile deactivation apparatus.

Abstract: A method of decontaminating a surface or liquid which is contaminated with prions includes treating the surface with a composition which includes one or more phenol. Phenols which are particularly effective include p-chloro-m-xylanol, thymol, triclosan, 4-chloro, 3-methylphenol, pentachlorophenol, hexachlorophene, 2,2-methyl-bis(4-chlorophenol), and p-phenylphenol.

Abstract: A surface which carries a material which is infected with prions is cleaned with an alkaline cleaning solution to remove as much proteinaceous material as possible from the surface. The solution contains an alkaline cleaning agent which attacks prions remaining on the surface and which attacks prions removed from the surface during the cleaning step. After the cleaning step, the surface is exposed to a strong gaseous oxidant, preferably hydrogen peroxide vapor. The hydrogen peroxide or other strong oxidant attacks the prions, particularly the unclumped prion strands, deactivating the prions.

Abstract: When microbial contamination is introduced into a room (20*) of an enclosure, such as a building, an HVAC system including supply ductwork (16) and a return ductwork (34) is decontaminated with hydrogen peroxide vapor. A decontamination controller (46) operates controllable baffles (22) at outlet registers (20), temporary controllable baffles (44) at inlet registers (30), and a blower system (10) to circulate hydrogen peroxide vapor from hydrogen peroxide vapor generators (42) through the ductwork in both forward and reverse directions. Further, at least portions of the baffles are closed to create dwell times in which the hydrogen peroxide vapor resides in the ductwork with minimal or turbulent flow.

Abstract: An oxidizing liquid (20), such as hydrogen peroxide, is vaporized (18) and the vapor is used to deactivate nerve gas, blistering gas, or other biologically active substances such as pathogens, biotoxins, and prions. A second chemical compound (42) in vapor, mist, or fog form is used in conjunction with the oxidizing vapor. In one embodiment, the second chemical preconditions the biologically active substances to be deactivated more efficiently by the oxidizing vapor. In another embodiment, the second chemical boosts the reactivity of the oxidizing vapor. In another embodiment, the other chemical reacts with the oxidizing vapor to form an intermediate compound that deactivates at least some of the biologically active substances.

Abstract: An oxidizing liquid (20), such as hydrogen peroxide, is vaporized (18) and the vapor is used to deactivate nerve gas, blistering gas, or other biologically active substances such as pathogens, biotoxins, and prions. A second chemical compound (42) in vapor, mist, or fog form is used in conjunction with the oxidizing vapor. In one embodiment, the second chemical preconditions the biologically active substances to be deactivated more efficiently by the oxidizing vapor. In another embodiment, the second chemical boosts the reactivity of the oxidizing vapor. In another embodiment, the other chemical reacts with the oxidizing vapor to form an intermediate compound that deactivates at least some of the biologically active substances.

Abstract: An indicator device for determining the efficacy of an antimicrobial treatment process. The indicator device includes an active agent encapsulated in an encapsulation component. The encapsulation components preferably takes the form of an electrospun nanofiber including a polymer.

Abstract: An indicator device for determining the efficacy of an antimicrobial treatment process. The indicator device includes an active agent encapsulated in an encapsulation component. The encapsulation components preferably takes the form of an electrospun nanofiber including a polymer.

Abstract: Compositions and methods for deactivating articles contaminated with nanobacteria, generally comprise a dispersant and/or a dissolution agent, and a deactivator. The methods and compositions of the invention are advantageously utilized to decontaminate and/or sterilize various articles such as medical and manufacturing devices or surfaces.

Abstract: The disclosed invention relates to prion deactivating compositions and methods for using the same. The prion deactivating composition may comprise at least one prion denaturing agent and at least one prion deactivating enzyme. The invention relates to a method of cleaning and/or sterilizing a material contaminated with infectious proteins.

Abstract: A method of treating the surfaces of medical instruments which are contaminated with prions includes contacting the surface with a composition containing a source of peroxide ions, such as hydrogen peroxide, at a molar concentration of at least 1.5M peroxide (equivalent to approximately 5% hydrogen peroxide) and preferably, about 2M peroxide (approximately 7% hydrogen peroxide). The composition is optionally in the form of a gel. The composition is retained in contact with the surfaces for about 1-2 hours until all or substantially all prion contamination is removed.

Abstract: When microbial contamination is introduced into a room (20*) of an enclosure, such as a building, an HVAC system including supply ductwork (16) and a return ductwork (34) is decontaminated with hydrogen peroxide vapor. A decontamination controller (46) operates controllable baffles (22) at outlet registers (20), temporary controllable baffles (44) at inlet registers (30), and a blower system (10) to circulate hydrogen peroxide vapor from hydrogen peroxide vapor generators (42) through the ductwork in both forward and reverse directions. Further, at least portions of the baffles are closed to create dwell times in which the hydrogen peroxide vapor resides in the ductwork with minimal or turbulent flow.

Abstract: When microbial contamination is introduced into a room (20*) of an enclosure, such as a building, an HVAC system including supply ductwork (16) and a return ductwork (34) is decontaminated with hydrogen peroxide vapor. A decontamination controller (46) operates controllable baffles (22) at outlet registers (20), temporary controllable baffles (44) at inlet registers (30), and a blower system (10) to circulate hydrogen peroxide vapor from hydrogen peroxide vapor generators (42) through the ductwork in both forward and reverse directions. Further, at least portions of the baffles are closed to create dwell times in which the hydrogen peroxide vapor resides in the ductwork with minimal or turbulent flow.

Abstract: Mail which may be contaminated with a biotoxin, such as Anthrax, is received in a preliminary sorting area (16) including a dirty side sorting room (40) that is sealed to the ambient environment. The mail is loaded into a pass-through decontamination system (22) in which the mail is sterilized or otherwise decontaminated. The mail is removed from the pass-through system in a second or clean room (18) which is isolated from the first. The mail is then sorted and processed in the lean room (18). In the event that the sorting room (40) becomes contaminated or is suspected of being contaminated by pathogenic biological or chemical agents, a spray system (86) supplies a decontamination gas into the preliminary sorting area (16) to decontaminate the dirty side sorting room (40), any equipment (42, 44) in the room, and any mail located in the room.

Abstract: A method of treating the surfaces of medical instruments which are contaminated with prions includes contacting the surface with a composition containing a source of peroxide ions, such as hydrogen peroxide, at a molar concentration of at least 1.5M peroxide (equivalent to approximately 5% hydrogen peroxide) and preferably, about 2M peroxide (approximately 7% hydrogen peroxide). The composition is optionally in the form of a gel. The composition is retained in contact with the surfaces for about 1–2 hours until all or substantially all prion contamination is removed.